Molecular insights into the anti‐inflammatory and antifibrotic effects of licorice–ginger decoction in experimental models of inflammatory arthritis‐associated lung fibrosis
Immunology & Cell Biology · 2026
DOI: 10.1111/imcb.70136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology & Cell Biology, 2026. Verfasst von Hui Yuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Immunology and Hematology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, China. Hauptthemen laut MEDLINE: Glycyrrhiza, Pulmonary Fibrosis, Anti-Inflammatory Agents, Antifibrotic Agents. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Basic Research Program of Shaanxi Province, National Natural Science Foundation of China, Qinchuangyuan Traditional Chinese Medicine Industry Innovation Cluster Project.
Abstract (Originalsprache)
Rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) is a severe autoimmune complication lacking effective treatments. This study investigates the molecular mechanisms underlying the therapeutic effects of licorice–ginger decoction (GGD) in experimental models relevant to arthritis‐associated lung fibrosis. Utilizing network pharmacology, transcriptomic sequencing, and molecular docking analyses, we identified the STAT1/ICAM1/IL‐17A signaling pathway as crucial for GGD efficacy. Experimental validation in both cellular and murine models demonstrated that GGD markedly alleviated body weight loss, reduced arthritis severity, and improved pulmonary pathological injury under inflammatory arthritis conditions. Mechanistic analyses revealed direct binding of Kae and QR to STAT1/ICAM1, leading to IL‐17A inhibition and mitigation of epithelial–mesenchymal transition (EMT) and fibroblast activation. Notably, overexpression of STAT1 attenuated the therapeutic effects of GGD. This study provides mechanistic insights into the anti‐inflammatory and antifibrotic effects of GGD in experimental models relevant to arthritis‐associated lung fibrosis and offers a potential framework for future mechanistic studies and translational research of classical Chinese formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Immunology and Hematology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, China.
- College of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang, 712000, China.
- Department of Radiology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, China.
ORCID-Profile: Hui Yuan
Förderung
- Natural Science Basic Research Program of Shaanxi Province
- National Natural Science Foundation of China
- Qinchuangyuan Traditional Chinese Medicine Industry Innovation Cluster Project
- Shaanxi Province Outstanding Traditional Chinese Medicine Talent Training Program
Zitieren
APA
Yuan, H., Leng, W., Bai, Y., Yu, N., Yu, Y., Yang, C., & Wu, Q. (2026). Molecular insights into the anti‐inflammatory and antifibrotic effects of licorice–ginger decoction in experimental models of inflammatory arthritis‐associated lung fibrosis. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70136
Vancouver
Yuan H, Leng W, Bai Y, Yu N, Yu Y, Yang C, et al. Molecular insights into the anti‐inflammatory and antifibrotic effects of licorice–ginger decoction in experimental models of inflammatory arthritis‐associated lung fibrosis. Immunology & Cell Biology. 2026. doi:10.1111/imcb.70136
BibTeX
@article{Yuan2026,
author = {Yuan, Hui and Leng, Wei and Bai, Yanrong and Yu, Nan and Yu, Yong and Yang, Chuangbo and Wu, Qian},
title = {Molecular insights into the anti‐inflammatory and antifibrotic effects of licorice–ginger decoction in experimental models of inflammatory arthritis‐associated lung fibrosis},
journal = {Immunology & Cell Biology},
year = {2026},
doi = {10.1111/imcb.70136}
}
EUVIMED